{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:05:23Z","timestamp":1761962723780},"reference-count":46,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1966,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0714.2010.00897.x","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T05:24:15Z","timestamp":1273728255000},"page":"497-505","source":"Crossref","is-referenced-by-count":7,"title":["Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?"],"prefix":"10.1111","volume":"39","author":[{"given":"C.","family":"Kragelund","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Reibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nauntofte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Torpet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/j.1875-9114.1994.tb02852.x","article-title":"Drug-induced lichen planus","volume":"14","author":"Thompson","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB3|cit3","first-page":"CD001168","article-title":"Interventions for treating oral lichen planus","volume":"2","author":"Chan","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clindermatol.2004.06.005","article-title":"Life-threatening graft-vs-host disease","volume":"23","author":"Vargas-Diez","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1601-0825.1997.tb00013.x","article-title":"Oral lichenoid drug eruptions","volume":"3","author":"McCartan","year":"1997","journal-title":"Oral Dis"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0190-9622(93)70176-T","article-title":"Lichenoid drug eruptions","volume":"29","author":"Halevy","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0030-4220(78)90383-3","article-title":"Definition of leukoplakia and related lesions: an aid to studies on oral precancer","volume":"46","author":"Kramer","year":"1978","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0904-2512.2001.00174.x","article-title":"Interobserver and intraobserver variability in the clinical assessment of oral lichen planus","volume":"31","author":"Van Der Meij","year":"2002","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0714.1999.tb02038.x","article-title":"Interobserver and intraobserver variability in the histologic assessment of oral lichen planus","volume":"28","author":"Van Der Meij","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0030-4220(87)90029-6","article-title":"The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions","volume":"64","author":"Potts","year":"1987","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1079-2104(05)80072-1","article-title":"Basal cell cytoplasmic autoantibodies in oral lichenoid reactions","volume":"79","author":"Lamey","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s002280050445","article-title":"Polypharmacy: correlations with sex, age and drug regimen. A prescription database study","volume":"54","author":"Bjerrum","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1601-0825.2003.02892.x","article-title":"Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes","volume":"9","author":"Kragelund","year":"2003","journal-title":"Oral Dis"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0098-2997(99)00005-9","article-title":"Human cytochromes P450","volume":"20","author":"Hasler","year":"1999","journal-title":"Mol Aspects Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele rrequency in European Caucasians, Asians, Africans and their descendants","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002280050615","article-title":"CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences","volume":"55","author":"Tamminga","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.mp.4001494","article-title":"Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response","volume":"9","author":"Kirchheiner","year":"2004","journal-title":"Mol Psychiatry"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00228-004-0766-8","article-title":"Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting","volume":"60","author":"Grasmader","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0714.2008.00702.x","article-title":"Polymorphic drug metabolizing CYP-enzymes - a pathogenic factor in oral lichen planus?","volume":"38","author":"Kragelund","year":"2009","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0009-9236(03)00120-6","article-title":"Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humans","volume":"74","author":"Werner","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2125.1986.tb05250.x","article-title":"Sparteine oxidation is practically abolished in quinidine-treated patients","volume":"22","author":"Brinn","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB22|cit22","unstructured":"Flockhart DA Cytochrome P450 Drug Interaction Table http:\/\/medicine.iupui.edu\/clinpharm\/ddis\/table.asp"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00008571-200208000-00008","article-title":"The interindividual differences in the 3-demthylation of caffeine alias CYP1A2 is determined by both genetic and environmental factors","volume":"12","author":"Rasmussen","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/clpt.1989.63","article-title":"S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin","volume":"45","author":"Sanz","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/clpt.1982.4","article-title":"Sparteine metabolism in Canadian Caucasians","volume":"31","author":"Vinks","year":"1982","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00008571-199408000-00005","article-title":"The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes","volume":"4","author":"Bock","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3109\/03602539709002246","article-title":"Regulation of cytochromes P450 during inflammation and infection","volume":"29","author":"Morgan","year":"1997","journal-title":"Drug Metab Rev"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB28|cit28","first-page":"254","article-title":"Important role of proinflammatory cytokines\/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections\/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes\/cytokines may markedly contribute to this pathology","volume":"12","author":"Prandota","year":"2005","journal-title":"Am J Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/154411130201300405","article-title":"The pathogenesis of oral lichen planus","volume":"13","author":"Sugerman","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1034\/j.1600-0714.2000.290802.x","article-title":"TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation","volume":"29","author":"Sklavounou","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s004030050442","article-title":"T lymphocytes and altered keratinocytes express interferon-gamma and interleukin 6 in lichen planus","volume":"291","author":"Fayyazi","year":"1999","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1067\/mcp.2000.103860","article-title":"In vivo effects of interleukin-10 on human cytochrome P450 activity","volume":"67","author":"Gorski","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1172\/JCI117582","article-title":"Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism","volume":"94","author":"Shedlofsky","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00544597","article-title":"Drug-related problems causing admission to a medical clinic","volume":"20","author":"Bergman","year":"1981","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2174\/1568026043387791","article-title":"Genotyping as a tool to predict adverse drug reactions","volume":"4","author":"Guzey","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/moe.2003.115","article-title":"Amalgam-contact hypersensitivity lesions and oral lichen planus","volume":"95","author":"Thornhill","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","article-title":"Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry","volume":"369","author":"Zanger","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/clpt.1984.256","article-title":"Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism","volume":"36","author":"Wedlund","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB39|cit39","volume-title":"Guidelines for ATC Classification","year":"1993"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050329","article-title":"Methods for estimating the occurrence of polypharmacy by means of a prescription database","volume":"53","author":"Bjerrum","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1081\/DMR-120018248","article-title":"Interactions of herbs with cytochrome P450","volume":"35","author":"Zhou","year":"2003","journal-title":"Drug Metab Rev"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.lfs.2005.12.009","article-title":"Evidence-based drug-herbal interactions","volume":"78","author":"Chavez","year":"2006","journal-title":"Life Sci"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/pds.1173","article-title":"The impact of cytochrome P450-2D6 genotype on the use and interpretation of therapeutic drug monitoring in long-stay patients treated with antidepressant and antipsychotic drugs in daily psychiatric practice","volume":"15","author":"Mulder","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB44|cit44","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6215-7-9","article-title":"What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies","volume":"7","author":"McDonald","year":"2006","journal-title":"Trials"},{"key":"10.1111\/j.1600-0714.2010.00897.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0714.1988.tb01527.x","article-title":"Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients","volume":"17","author":"Thorn","year":"1988","journal-title":"J Oral Pathol"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2010.00897.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0714.2010.00897.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T19:14:29Z","timestamp":1711480469000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2010.00897.x"}},"subtitle":["Oral lichenoid drug eruptions and impaired CYP activity"],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":46,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2010.00897.x","relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}